Earth-friendly micellar UPLC technique for determination of four hypoglycemic drugs in different pharmaceutical dosage forms and spiked human plasma
Abstract A novel, sensitive, and green micellar UPLC method was proposed and validated for the simultaneous determination of four hypoglycemic agents used in type II diabetes mellitus treatment namely, pioglitazone, alogliptin, glimepiride, and vildagliptin. The developed UPLC method was successfull...
Main Authors: | Manal S. Elmasry, Wafaa S. Hassan, Hanan A. Merey, Israa M. Nour |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | BMC Chemistry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13065-023-00983-6 |
Similar Items
-
Possibilities of application a fixed combination of alogliptin and pioglitazone for type 2 diabetes mellitus treatment
by: M. V. Shestakova, et al.
Published: (2021-07-01) -
Long-term results of transferring the patient from therapy with glucagon-like peptide-1 receptor agonists in combination with metformin to a dipeptidyl peptidase-4 inhibitor in combination with pioglitazone and inhibitor of type 2 sodium-glucose cotransporter in type 2 diabetes
by: V. V. Salukhov, et al.
Published: (2024-03-01) -
Eco-friendly HPLC method by using response surface design to measure a combination of three antidiabetic drugs
by: Al-Tannak Naser F., et al.
Published: (2023-11-01) -
Micellar liquid chromatographic determination of sertaconazole and terconazole in bulk, pharmaceutical dosage forms and spiked human plasma
by: Mohamed Rizk, et al.
Published: (2014-06-01) -
Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study
by: Eugenio Ragazzi, et al.
Published: (2023-08-01)